Adam S. Levy

Adam Levy, MD, is a Clinical Professor who works per diem at Montefiore Einstein in the trainee’s clinic. He specializes in general pediatric hematology and oncology, with a focus on tumors of the brain and spine, solid tumors and tumors associated with neurofibromatosis.

After receiving his Bachelor of Science at Cornell University, Dr. Levy earned his Doctor of Medicine at New York University School of Medicine. Following this, he completed training in pediatrics at Mount Sinai Medical Center in New York and became Chief Resident. Dr. Levy then completed a pediatric hematology/oncology fellowship at Memorial Sloan-Kettering and New York Hospital/Weill Cornell Medical Center, where he served as Chief Fellow.

Dr. Levy’s early research training in a transitional science laboratory focused on mechanisms and pathways explaining tumor cell chemotherapy resistance. He was the principal investigator for the Children’s Oncology Group, the nation's largest consortium of childhood cancer researchers, and currently leads an international clinical trial for children with recurrent brain tumors. As a clinical investigator, his current research focuses on using new drugs and treatment plans for pediatric cancer patients. He has studied and published ways to improve clinical care of patients, mentorship in pediatric oncology, communication skills training and burnout amongst clinicians. He has been an invited presenter on these topics nationally.

Dr. Levy is a member of the Society for Pediatric Research, and his efforts have been recognized numerous times as a New York Magazine Top Doctor. He has also won many awards, including the Children’s Tumor Foundation Humanitarian Award, The Davidoff Society Education Award and the Charles Trobman Memorial Award.

Brain and spinal cord tumors; pediatric solid tumors; neurofibromatosis

Dr. Levy practices general pediatric hematology-oncology with a focus on tumors of the brain and spine. Dr. Levy’s current research interests concern the use of new drugs and treatment plans for children with cancer.